Open AccessHEPATITIS C AND BETA-THALASSEMIA MAJOR IN CHILDREN: EXPERIENCE WITH GLECAPREVIR/PIBRENTASVIR
Author(s) -
Diannet Quintero García,
Francisco Cuevas,
Elena Crehuá-Gaudiza
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7092/2020
Subject(s) - medicine , hepatitis c , beta thalassemia , thalassemia , beta (programming language) , virology , pediatrics , computer science , programming language
Hepatitis C virus (HCV) is estimated to affect 3.26 million children worldwide, with the highest number of cases registered in Pakistan and China. Vertical transmission is the principal route in industrialized countries. However, iatrogenic transmission is relevant in low-income settings. We present the case of a 12-year-old Pakistani child who suffered from beta-thalassemia major and hepatitis C, successfully treated with glecaprevir/pibrentasvir.